NCT05266534View on ClinicalTrials.gov

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

NARecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

December 30, 2026

Conditions
Myoma
Interventions
DRUG

Terlipressin

the efficacy of intramyometrial Terlipressin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy

DRUG

Carbetocin

the efficacy of intramyometrial carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy

DRUG

Saline

the efficacy of intramyometrial saline injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy

Trial Locations (1)

Unknown

RECRUITING

Wael El Banna Clinic, Maadi

All Listed Sponsors
lead

Wael Elbanna Clinic

OTHER